Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Endocrinology · Type B Insulin Resistance Syndrome

The Glycemic Rollercoaster: Symptoms and Warning Signs

At a Glance

Type B Insulin Resistance Syndrome (TBIRS) causes extreme blood sugar instability because immune antibodies interfere with insulin receptors. Symptoms include severe high and low blood sugar, dark skin patches called acanthosis nigricans, rapid weight loss, and hormone imbalances.

Living with Type B Insulin Resistance Syndrome (TBIRS) often feels like being on a “glycemic rollercoaster” that you cannot control. The condition doesn’t just cause high blood sugar; it fundamentally breaks how your body processes energy, leading to a unique and often confusing set of physical and metabolic symptoms [1][2].

The Glycemic Rollercoaster

The hallmark of TBIRS is the presence of insulin receptor autoantibodies (IRAbs). These are proteins made by your immune system that target the “locks” (receptors) on your cells. Depending on how these antibodies behave at any given moment, you may experience two extremes [2][3]:

  • Extreme Hyperglycemia (High Blood Sugar): Most of the time, these antibodies act as “blockers.” They sit on the insulin receptor and prevent insulin from opening the cell. This causes sugar to build up in your blood to dangerous levels, even if you are taking thousands of units of insulin [4][5].
  • Paradoxical Hypoglycemia (Low Blood Sugar): In some cases, the same antibodies can suddenly act like insulin itself. They “turn on” the receptor even when no insulin is present. This can lead to sudden, severe drops in blood sugar, particularly after fasting (like when you wake up in the morning) [2][6].

Physical Signs and Skin Changes

Beyond the numbers on your glucose monitor, TBIRS causes visible changes to your body.

  • Acanthosis Nigricans: These are dark, velvety patches of skin that typically appear in body folds, such as the neck, armpits, or groin [3][7]. Because your receptors are blocked, your body compensates by pumping out massive amounts of insulin. This extreme “hyperinsulinemia” spills over and interacts with IGF-1 receptors (growth receptors) in your skin, causing the skin cells to multiply rapidly and thicken [8].
  • Hyperandrogenism: In female patients, the massive amounts of circulating insulin can overstimulate the ovaries, causing them to produce excess male hormones (androgens). This can lead to symptoms like irregular menstrual periods, excessive hair growth on the face or body (hirsutism), and virilization [4][3].
  • Rapid Weight Loss: Many patients experience a catabolic state, which is a medical term for the body breaking down its own tissue for energy [9]. This often results in rapid, unexplained weight loss (cachexia), even if you are eating normally, because your cells are “starving” for the glucose trapped in your bloodstream [10][11].

The Autoimmune Connection

TBIRS rarely travels alone. Because it is an autoimmune disease, it is frequently linked to other conditions where the immune system attacks the body. The most common partner is Systemic Lupus Erythematosus (SLE) [12].

If you have an underlying condition like SLE, you may notice symptoms beyond blood sugar issues, such as [13][14]:

  • Severe fatigue and exhaustion.
  • Joint pain or swelling.
  • Unexplained fevers.
  • Rashes, such as a “butterfly rash” across the nose and cheeks.

Monitoring these broader symptoms is vital, as a “flare” in an underlying autoimmune disease can sometimes trigger or worsen the blood sugar instability of TBIRS [10]. Recognizing these signs early allows your care team to adjust your treatment plan to address both the metabolic and immunological aspects of the disease.

Common questions in this guide

Why does my blood sugar sometimes drop so low with TBIRS?
In TBIRS, autoantibodies usually block insulin receptors, causing high blood sugar. However, these same antibodies can sometimes mimic insulin and activate the receptors, leading to sudden and severe drops in blood sugar, especially after fasting.
What causes the dark patches of skin in body folds?
These dark, velvety skin patches are called acanthosis nigricans. They develop because your body produces massive amounts of insulin to try and overcome the blocked receptors. This excess insulin overstimulates growth receptors in your skin, causing cells to multiply and thicken.
Why am I losing weight so rapidly with this condition?
Because your cells cannot access the sugar trapped in your bloodstream, your body thinks it is starving. It enters a catabolic state, breaking down its own muscle and fat tissue for energy, which causes rapid weight loss even if you are eating normally.
Is TBIRS connected to other autoimmune diseases?
Yes, TBIRS is an autoimmune condition that is frequently linked to other autoimmune diseases, most commonly Systemic Lupus Erythematosus (SLE). A flare in underlying lupus can sometimes trigger or worsen your blood sugar symptoms.
Will the dark skin patches fade over time?
The dark patches of acanthosis nigricans may improve as your underlying insulin resistance is successfully managed and your body stops overproducing insulin. Your doctor can help monitor these skin changes as your treatment progresses.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How should I adjust my insulin dose if my blood sugar starts dropping unexpectedly during fasting?
  2. 2.Can we screen for lupus or other autoimmune conditions since they are often linked to TBIRS?
  3. 3.Are the dark patches on my skin (acanthosis nigricans) expected to fade as my treatment progresses?
  4. 4.Is my rapid weight loss a sign of the 'catabolic state' associated with this syndrome, and how can we manage my nutrition?
  5. 5.What specific blood sugar levels should trigger an emergency call to your office?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Rituximab for the treatment of type B insulin resistance syndrome: a case report and review of the literature.

    Iseri K, Iyoda M, Shikida Y, et al.

    Diabetic medicine : a journal of the British Diabetic Association 2017; (34(12)):1788-1791 doi:10.1111/dme.13524.

    PMID: 29044634
  2. 2

    Insulin autoimmune syndrome: from diagnosis to clinical management.

    Censi S, Mian C, Betterle C

    Annals of translational medicine 2018; (6(17)):335 doi:10.21037/atm.2018.07.32.

    PMID: 30306074
  3. 3

    Type B insulin resistance syndrome associated with connective tissue disease and psoriasis.

    Łebkowska A, Krentowska A, Adamska A, et al.

    Endocrinology, diabetes & metabolism case reports 2020; (2020()).

    PMID: 32755965
  4. 4

    Rare case of type B insulin resistance in association with systemic lupus erythematosus: illustrating diagnostic and management challenges.

    Saqib A, Man Y, Ismail R, Kariyawasam D

    BMJ case reports 2021; (14(8)) doi:10.1136/bcr-2021-242960.

    PMID: 34340988
  5. 5

    Management of a patient with severe insulin resistance.

    Arulanandam B, Garfield N

    JCEM case reports 2026; (4(8)):luag200 doi:10.1210/jcemcr/luag200.

    PMID: 42488373
  6. 6

    Endogenous hyperinsulinemic hypoglycemia: case series and literature review.

    Zhang C, Zhang H, Huang W

    Endocrine 2023; (80(1)):40-46 doi:10.1007/s12020-022-03268-5.

    PMID: 36459334
  7. 7

    An African American Male Patient with Rare Type B Insulin Resistance Syndrome.

    Jialal I, Devaraj S

    Laboratory medicine 2022; (53(2)):215-217 doi:10.1093/labmed/lmab076.

    PMID: 34508269
  8. 8

    A 4-month-old female infant with breast development and virilisation.

    Journal of paediatrics and child health 2023; (59(3)):593 doi:10.1111/jpc.1_15994.

    PMID: 36987551
  9. 9

    Diabetic Ketoacidosis Without Diabetes.

    Willard D, Upadhyay J, Kim C, Steenkamp D

    The Journal of clinical endocrinology and metabolism 2016; (101(11)):3870-3873 doi:10.1210/jc.2016-2146.

    PMID: 27636019
  10. 10

    Antibody-Mediated Extreme Insulin Resistance: A Report of Three Cases.

    Kim HN, Fesseha B, Anzaldi L, et al.

    The American journal of medicine 2018; (131(1)):102-106 doi:10.1016/j.amjmed.2017.08.004.

    PMID: 28822702
  11. 11

    Systemic Lupus Erythematosus and Lupus Nephritis Presenting as Severe Constitutional Symptoms.

    La T, Ansari S, Ha E, Novakovic M

    Cureus 2024; (16(3)):e56670 doi:10.7759/cureus.56670.

    PMID: 38646266
  12. 12

    A case of systemic lupus erythematosus in a patient with Noonan syndrome with recurrent severe hypoglycaemia.

    Masuoka S, Tanaka T, Kanaji M, et al.

    Modern rheumatology case reports 2024; (8(2)):280-285 doi:10.1093/mrcr/rxae004.

    PMID: 38252597
  13. 13

    Type B Insulin Resistance Syndrome: A Rare Cause of Hypoglycemia.

    Bhat SZ, Lim S, Sidhaye A, Hamrahian AH

    JCEM case reports 2023; (1(5)):luad104 doi:10.1210/jcemcr/luad104.

    PMID: 37908220
  14. 14

    Risk factors of lower urinary tract symptoms measured by the International Consultation on Incontinence Modular Questionnaire in females with lupus cystitis: A case-control study.

    Faddan AA, Gadelkareem RA, Hassanien M, et al.

    Current urology 2025; (19(4)):269-273 doi:10.1097/CU9.0000000000000276.

    PMID: 40765529

This page provides educational information about the symptoms of Type B Insulin Resistance Syndrome. It is not a substitute for professional medical advice, diagnosis, or treatment.

Get notified when new evidence is published on Insulin-resistance syndrome type B.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.